A new compound is gaining traction in performance science and biochemical research: MK-777 (Acetamoren). Positioned as a next-generation analogue of MK-677 (Ibutamoren), MK-777 has attracted increasing attention in early 2025 for its potential to replicate the growth hormone–stimulating effects of its predecessor while demonstrating greater receptor selectivity and a reduced propensity for side effects in laboratory models.
Interest is building across research circles, bodybuilding communities, and performance science alike. As growth hormone secretagogues (GHS) return to prominence, MK-777 is emerging as a potential evolution of an already well-established mechanism.
What Is MK-777 (Acetamoren)?
MK-777 (Acetamoren) is an investigational growth hormone secretagogue analog designed by independent research labs in 2024. It belongs to the same family of ghrelin receptor agonists as MK-677 but is claimed to be engineered for greater receptor affinity and reduced off-target metabolic activity.
Scientific summary:
- Compound type: Non-peptide small molecule
- Mechanism: Ghrelin receptor agonist (GHS-R1a)
- Objective: Stimulate GH and IGF-1 release in controlled environments
- Development intent: Improved binding efficiency and receptor sensitivity
- Status: Very early research stage, unapproved by the FDA and EMA for any medical use
While direct peer-reviewed data on MK-777 remain limited, its structural intent suggests an evolution of MK-677’s pharmacodynamics—refining, not reinventing, the original model.
About GH secretagogues
Growth hormone secretagogues (GHS) are compounds that stimulate the natural release of GH through the body’s ghrelin receptor (GHS-R1a).
- MK-677 (Ibutamoren) mimics ghrelin, the “hunger hormone,” triggering the secretion of Growth Hormone (GH) and Insuline-like Growth Factor 1 (IGF-1).
- MK-777 (Acetamoren) was developed as an analog, with potential receptor refinements aimed at optimizing that same GH pulse.
The key difference? MK-777 attempts to maintain GH stimulation while reducing appetite spikes and fluid retention sometimes noted in MK-677 research.
Comparison overview: MK-777 vs MK-677
| Feature | MK-677 (Ibutamoren) | MK-777 (Acetamoren) |
|---|---|---|
| Generation | GH secretagogue | GH secretagogue analog |
| Mechanism | Ghrelin receptor agonist | Selective ghrelin receptor analog |
| GH/IGF-1 Output | Strong and well-documented | Expected similar, under study |
| Effect on appetite | Strong ghrelin-like hunger increase | Milder effect on appetite according to community reports |
| Water Retention | Common side effect | Less effect on appetite according to community reports |
| Metabolic Stability | Slight insulin sensitivity impact | Designed for smoother glucose balance |
| Research Stage | Extensively studied | Early exploratory phase |
| Half-life | ~24 hours | Currently unknown |
MK-677 is well-known for its strong ability to stimulate appetite and significantly elevate growth hormone (GH) levels for extended periods. In contrast, MK-777 is currently undergoing early-stage research and seems to be potentially more tolerable, with fewer peripheral side effects. However, there is still limited data available on MK-777, and further investigation is needed to understand its stability, bioavailability, and long-term effects.
Potential benefits
Because MK-777 is a completely new compound, there are currently no human trials or peer-reviewed studies on this compound. The potential benefits listed below are therefore based on theoretical properties from analog modelers. There is a growing number of user reports about MK-777 found on Reddit and other platforms that provide some anecdotal evidence.
| Research Focus | Hypothesized Outcome |
|---|---|
| GH/IGF-1 Secretion | Expected to mimic MK-677’s GH-axis activation in a possibly more selective manner. |
| Reduced Appetite Impact | May produce weaker hunger-stimulating effects due to altered receptor binding. |
| Water Retention | Some researchers anticipate lower sodium/water shifts compared to Ibutamoren. |
| Bioavailability | Designed for more stable absorption, resulting in a more consistent growth hormone response curve. |
| Receptor Efficiency | May sustain GH release with smaller fluctuations in binding activity. |
Legal status
The legal status of MK-777 (Acetamoren) is exactly the same as that of MK-677 (Ibutamoren).
- For research and educational use only
- Not FDA or EMA approved for human consumption
- Not classified as a dietary supplement
- Must be labeled “Not for human use” for compliance
Neither compound is legal for use in competitive sports or over-the-counter supplement products. Researchers must handle both within appropriate legal frameworks.
HQSARMS is committed to upholding the highest standards by providing MK-777 exclusively as a premium laboratory-grade research compound.
Where to buy MK-777 (Acetamoren)
If you live in Europe, you can buy MK-777, and many other research compounds in liquid form at HQSARMS.
Frequently asked questions
What is the difference between MK-677 and MK-777?
The major difference is that MK-777 (Acetamoren) is an emerging analog designed to refine the same growth hormone–stimulating pathway established by MK-677 (Ibutamoren). While both act on the ghrelin receptor, MK-777 is being explored for potentially improved receptor selectivity and a cleaner endocrine response in research settings.
Is MK-777 a legal replacement for MK-677?
No. The legal status of both compounds is exactly the same. They have not been approved by the FDA or EMA for medical use and can only be sold for research purposes, not for human consumption.
Are there any published studies on MK-777?
As of 2026, there are no peer-reviewed studies. All available information is based on analog modeling and, early-stage lab exploration and anecdotal evidence.
How does MK-777 compare to peptides?
Unlike injectable peptides such as GHRP-6 and Ipamorelin, MK-777 is an orally active non-peptide agonist, offering easier study protocols and distinct pharmacokinetics.